#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17402	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2259	767.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1461	1461	C	1005	C	951	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3571	894.5	0	.	n	.	0	T695C	SNP	695	695	T	1000	1000	C	987	C,T	934,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3571	894.5	0	.	n	.	0	G856C	SNP	856	856	G	1161	1161	C	1168	C,G	1098,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3571	894.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1642	1642	A	1071	A	1012	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3571	894.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2276	2276	C	1041	C,A	959,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3571	894.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2350	2350	A	962	A	917	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32052	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3571	894.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2902	2902	C	988	C	942	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	R7Q	NONSYN	19	21	CGG	335	337	CAG	120;121;122	C;A;G	114;114;115	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	E12K	NONSYN	34	36	GAA	350	352	AAA	138;139;137	A,G;A;A	132,1;134;134	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	F31L	NONSYN	91	93	TTT	407	409	TTG	164;164;167	T;T;G	154;155;156	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	S68P	NONSYN	202	204	TCG	518	520	CCG	170;165;164	C;C;G	155;155;151	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	F72Y	NONSYN	214	216	TTC	530	532	TAT	161;162;160	T;A;T	154;155;153	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	P74S	NONSYN	220	222	CCG	536	538	TCG	165;167;168	T;C;G	159;158;159	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	A89V	NONSYN	265	267	GCG	581	583	GTG	167;170;168	G;T;G	157;153;159	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	V130L	NONSYN	388	390	GTC	704	706	CTC	214;215;213	C;T;C	198;201;201	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	R135C	NONSYN	403	405	CGC	719	721	TGT	215;215;213	T;G;T	194;202;196	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	R147Q	NONSYN	439	441	CGG	755	757	CAG	218;221;221	C;A;G	209;214;212	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	767	769	AAG	213;218;212	A;A;G	207;212;208	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	T152N	NONSYN	454	456	ACC	770	772	AAT	213;213;215	A;A;T	208;208;210	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	D155I	NONSYN	463	465	GAC	779	781	ATT	221;219;219	A;T;T	209;212;212	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	T172A	NONSYN	514	516	ACA	830	832	GCG	213;215;216	G;C;G	196;198;197	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	S174A	NONSYN	520	522	TCA	836	838	GCG	212;212;213	G;C;G	195;196;196	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	E175A	NONSYN	523	525	GAA	839	841	GCG	213;211;211	G;C;G	197;193;197	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	T176E	NONSYN	526	528	ACC	842	844	GAA	212;211;212	G;A;A	194;197;197	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	V178I	NONSYN	532	534	GTC	848	850	ATC	211;211;209	A;T;C	198;195;192	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1958	folP	852	852	94.02	folP.l15.c4.ctg.1	1570	124.1	0	.	p	.	0	K197fs	FSHIFT	589	589	A	905	905	A	186	A	176	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6000	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3389	176.2	1	SNP	p	S91F	0	.	.	271	273	TCC	529	531	TCC	199;197;199	T;C,T;C	183;179,1;182	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6000	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3389	176.2	1	SNP	p	D95N	0	.	.	283	285	GAC	541	543	GAC	183;183;184	G;A,G;C	168;168,1;171	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6000	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3389	176.2	1	SNP	p	D95G	0	.	.	283	285	GAC	541	543	GAC	183;183;184	G;A,G;C	168;168,1;171	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1852	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1395	132.2	1	SNP	p	G45D	1	.	.	133	135	GAC	558	560	GAC	221;219;221	G;A;C	213;210;213	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1008	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1057	94.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5794	parC	2304	2304	99.78	parC.l6.c4.ctg.1	3012	191.5	1	SNP	p	D86N	0	.	.	256	258	GAC	607	609	GAC	225;225;227	G;A;C	210;206;213	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5794	parC	2304	2304	99.78	parC.l6.c4.ctg.1	3012	191.5	1	SNP	p	S88P	0	.	.	262	264	TCC	613	615	TCC	231;232;233	T;C;C	216;213;218	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4774	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2739	173.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1579	1581	GGC	237;234;231	G,A;G;C	222,1;221;214	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1270	1272	GCA	223;224;225	G;C;A	210;206;212	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1273	1275	ATC	225;225;229	A;T;C	212;213;214	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1285	1287	GTG	227;227;228	G;T;G	215;215;216	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1285	1287	GTG	227;227;228	G;T;G	215;215;216	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1789	1791	ACC	235;234;234	A;C;C,A	216;221;217,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1843	1845	GCG	204;202;202	G;C;G	184;165;173	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1843	1845	GCG	204;202;202	G;C;G	184;165;173	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1966	1968	GGC	229;228;227	G;G;C	207;206;207	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1975	1977	GGC	229;229;226	G;G;C	202;199;201	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4512	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2409	186.6	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1993	1995	CTG	211;211;213	C,G;T,C;G	172,4;160,1;168	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6382	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3087	206.0	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1636	1638	CCG	243;242;244	C;C;G	226;231;230	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2346	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1883	124.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	347	349	GGC	165;166;168	G;G,A;C	151;150,1;151	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2346	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1883	124.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	529	529	C	159	C	149	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3366	porB1b	1035	1035	99.04	porB1b.l15.c17.ctg.1	1652	201.6	0	.	p	.	0	R144Q	NONSYN	430	432	CGG	915	917	CAG	277;278;277	C;A;G,A	263;264;262,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3366	porB1b	1035	1035	99.04	porB1b.l15.c17.ctg.1	1652	201.6	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1119	1121	GAT	242;244;244	G;A;T	231;234;229	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3366	porB1b	1035	1035	99.04	porB1b.l15.c17.ctg.1	1652	201.6	0	.	p	.	0	S213fs	FSHIFT	637	637	A	1122	1122	A	241	A,G	231,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3366	porB1b	1035	1035	99.04	porB1b.l15.c17.ctg.1	1652	201.6	1	SNP	p	G120K	0	.	.	358	360	GGT	843	845	GGT	256;256;263	G;G,A;T	244;240,1;247	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3366	porB1b	1035	1035	99.04	porB1b.l15.c17.ctg.1	1652	201.6	1	SNP	p	A121D	0	.	.	361	363	GCC	846	848	GCC	263;261;261	G;C;C	250;249;246	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3366	porB1b	1035	1035	99.04	porB1b.l15.c17.ctg.1	1652	201.6	1	SNP	p	A121N	0	.	.	361	363	GCC	846	848	GCC	263;261;261	G;C;C	250;249;246	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12982	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4915	263.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1396	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1130	122.8	1	SNP	p	V57M	1	.	.	169	171	ATG	578	580	ATG	278;278;278	A;T;G	260;258;257	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
